These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 20224660)

  • 1. Induction/engineering, detection, selection, and expansion of clinical-grade human antigen-specific CD8 cytotoxic T cell clones for adoptive immunotherapy.
    Jeras M; Bricl I; Zorec R; Svajger U
    J Biomed Biotechnol; 2010; 2010():705215. PubMed ID: 20224660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro methods for generating CD8+ T-cell clones for immunotherapy from the naïve repertoire.
    Ho WY; Nguyen HN; Wolfl M; Kuball J; Greenberg PD
    J Immunol Methods; 2006 Mar; 310(1-2):40-52. PubMed ID: 16469329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of IL-21, IL-7, and IL-15 conditioned media for expansion of antigen-specific CD8+ T cells from healthy donor-PBMCs suitable for immunotherapy.
    Chamucero-Millares JA; Bernal-Estévez DA; Parra-López CA
    Cell Immunol; 2021 Feb; 360():104257. PubMed ID: 33387685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotype and functional evaluation of ex vivo generated antigen-specific immune effector cells with potential for therapeutic applications.
    Han S; Huang Y; Liang Y; Ho Y; Wang Y; Chang LJ
    J Hematol Oncol; 2009 Aug; 2():34. PubMed ID: 19660111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of Pure Highly Functional Human Anti-Tumor Specific Cytotoxic T Lymphocytes With Stem Cell-Like Memory Features for Melanoma Immunotherapy.
    Hamieh M; Chatillon JF; Dupel E; Bayeux F; Fauquembergue E; Maby P; Drouet A; Duval-Modeste AB; Adriouch S; Boyer O; Latouche JB
    Front Immunol; 2021; 12():674276. PubMed ID: 34566953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of highly proliferative, rejuvenated cytotoxic T cell clones through pluripotency reprogramming for adoptive immunotherapy.
    Kawai Y; Kawana-Tachikawa A; Kitayama S; Ueda T; Miki S; Watanabe A; Kaneko S
    Mol Ther; 2021 Oct; 29(10):3027-3041. PubMed ID: 34023508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large-scale expansion of γδ T cells and peptide-specific cytotoxic T cells using zoledronate for adoptive immunotherapy.
    Yoshikawa T; Takahara M; Tomiyama M; Nieda M; Maekawa R; Nakatsura T
    Int J Oncol; 2014 Nov; 45(5):1847-56. PubMed ID: 25189159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and expansion of allogeneic myeloma-specific interferon-gamma producing T cells for adoptive immunotherapy.
    Ocadlikova D; Zahradova L; Kovarova L; Penka M; Zaloudik J; Buchler T; Hajek R; Michalek J
    Med Oncol; 2006; 23(3):377-84. PubMed ID: 17018895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rebuilding human leukocyte antigen class II-restricted minor histocompatibility antigen specificity in recall antigen-specific T cells by adoptive T cell receptor transfer: implications for adoptive immunotherapy.
    Spaapen R; van den Oudenalder K; Ivanov R; Bloem A; Lokhorst H; Mutis T
    Clin Cancer Res; 2007 Jul; 13(13):4009-15. PubMed ID: 17606735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical grade generation of hexon-specific T cells for adoptive T-cell transfer as a treatment of adenovirus infection after allogeneic stem cell transplantation.
    Feuchtinger T; Richard C; Joachim S; Scheible MH; Schumm M; Hamprecht K; Martin D; Jahn G; Handgretinger R; Lang P
    J Immunother; 2008; 31(2):199-206. PubMed ID: 18481389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and expansion of tumor-reactive cytotoxic T-cell clones for adoptive immunotherapy.
    Bernhard H; Schmidt B; Busch DH; Peschel C
    Methods Mol Med; 2005; 109():175-84. PubMed ID: 15585921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GMP production of anti-tumor cytotoxic T-cell lines for adoptive T-cell therapy in patients with solid neoplasia.
    Turin I; Pedrazzoli P; Tullio C; Montini E; La Grotteria MC; Schiavo R; Perotti C; Locatelli F; Carretto E; Maccario R; Siena S; Montagna D
    Cytotherapy; 2007; 9(5):499-507. PubMed ID: 17786611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and expansion of human adenovirus-specific CD4+ and CD8+ T cells according to IFN-gamma secretion for adjuvant immunotherapy.
    Feuchtinger T; Lang P; Hamprecht K; Schumm M; Greil J; Jahn G; Niethammer D; Einsele H
    Exp Hematol; 2004 Mar; 32(3):282-9. PubMed ID: 15003314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A reproducible method for the expansion of mouse CD8+ T lymphocytes.
    Lewis MD; de Leenheer E; Fishman S; Siew LK; Gross G; Wong FS
    J Immunol Methods; 2015 Feb; 417():134-138. PubMed ID: 25602136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of Specific CD4+ and CD8+ T Cells Stimulated by CMV pp65 and IE1 Antigens.
    Albiero E; Amati E; Baumeister E; Einsele H; Grigoleit GU; Rodeghiero F
    J Immunother; 2016; 39(9):329-342. PubMed ID: 27631893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo expansion of hematopoietic cells and their clinical use.
    Aglietta M; Bertolini F; Carlo-Stella C; De Vincentiis A; Lanata L; Lemoli RM; Olivieri A; Siena S; Zanon P; Tura S
    Haematologica; 1998 Sep; 83(9):824-48. PubMed ID: 9825579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a clinical model for ex vivo expansion of multiple populations of effector cells for adoptive cellular therapy.
    Meehan KR; Wu J; Webber SM; Barber A; Szczepiorkowski ZM; Sentman C
    Cytotherapy; 2008; 10(1):30-7. PubMed ID: 18202972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large ex vivo expansion of human umbilical cord blood CD4+ and CD8+ T cells.
    Skea D; Chang NH; Hedge R; Dabek B; Wong T; Wettlaufer B; Bell D
    J Hematother; 1999 Apr; 8(2):129-39. PubMed ID: 10349907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB.
    Maus MV; Thomas AK; Leonard DG; Allman D; Addya K; Schlienger K; Riley JL; June CH
    Nat Biotechnol; 2002 Feb; 20(2):143-8. PubMed ID: 11821859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4-1BB-based isolation and expansion of CD8+ T cells specific for self-tumor and non-self-tumor antigens for adoptive T-cell therapy.
    Choi BK; Lee SC; Lee MJ; Kim YH; Kim YW; Ryu KW; Lee JH; Shin SM; Lee SH; Suzuki S; Oh HS; Kim CH; Lee DG; Hwang SH; Yu EM; Lee IO; Kwon BS
    J Immunother; 2014 May; 37(4):225-36. PubMed ID: 24714356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.